A Review of the Use of Antiepileptic Drugs in High-Grade Central Nervous System Tumors

American Journal of Hospice and Palliative Medicine

Volumn 29, Issue 8, 2012, Pages 618-621

  Wallace, Elaine M ^a   O'Reilly, Maeve ^a   Twomey, Marie ^a  

^a ST LUKE S HOSPITAL   (Ireland)

Author keywords

antiepileptics; brain tumors; CNS; palliative care; primary; seizures

Indexed keywords

ANTICONVULSIVE AGENT; PHENYTOIN;

ADULT; AGED; BRAIN TUMOR; CAR DRIVING; FEMALE; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; REVIEW; SEIZURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; AUTOMOBILE DRIVING; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENYTOIN; RETROSPECTIVE STUDIES; SEIZURES;

EID: 84869022653     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909111434367     Document Type: Review

References (16)

1. Prados MD,Levin V.Biology and treatment of malignant glioma.Semin Oncol. 2000;27 (3 suppl 6): 1-10.
2. Moots PL,Maciunas RJ,Eisert DR,Parker RA,Laporte K,Abou-Khalil B.The course of seizure disorders in patients with malignant gliomas.Arch Neurol. 1995;52 (7): 717-724.
3. Hildebrand J,Lecaille C,Perennes J,Delattre JY.Epileptic seizures during follow-up of patients treated for primary brain tumours.Neurology. 2005;65 (2): 212-215.
4. Herman ST.Epilepsy after brain insult: targeting epileptogenesis.Neurology. 2002;59 (9 suppl 5): S21-S26.
5. Olafsson E,Ludvigsson P,Gudmundsson G,Hesdorffer D,Kjartansson O,Hauser WA.Incidence of unproved seizures and epilepsy in Iceland and assessment of the epilepsy and syndrome classification: a prospective study.Lancet Neurol. 2005;4 (10): 627-634.
6. Wen PY,Marks PW.Medical management of patients with brain tumours.Curr Opin Oncol. 2002;14 (3): 299-307.
7. Van Breemen MS,Wilms EB,Vecht CJ.Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management.Lancet Neurol. 2007;6 (5): 421-430.
8. Vecht CJ,van Breemen M.Optimising therapy of seizures in patients with brain tumours.Neurology. 2006;67 (12 suppl 4): S10-S13.
9. Glantz MJ,Cole BF,Forsyth PA, et al.Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumours. Report of the quality standards subcommittee of the American academy of neurology.Neurology. 2000;54 (10): 1886-1893.
10. Ruiz-Gimenez J,Sanchez-Alvarez JC,Canadillas-Hidalgo F,Serrano-Castro PJ.Antiepileptic treatment in patients with epilepsy and other comorbidities.Seizure. 2010;19 (7): 375-382.
11. Novy J,Stupp R,Rossetti AO.Pregabalin in patients with primary brain tumours and seizures: a preliminary observation.Clin Neurol Neurosurg. 2009;111 (2): 171-173.
12. Rosati A,Buttolo L,Stefini R, et al.Efficacy and safety of levetiracetam in patients with glioma: a clinical prospective study.Arch Neurol. 2010;67 (3): 343-346.
13. Milligan TA,Hurwitz S,Bromfield EB.Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.Neurology. 2008;71 (9): 665-669.
14. Werk EE,Choi Y,Sholiton L,Olinger C,Haque N.Interference in the effect of dexamethasone by diphenylhydantoin.N Eng J Med. 1969;281 (1): 32-34.
15. Chalk JB,Ridgeway K,Brophy T,Yelland JD,Eadie MJ.Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients.J Neurol Neurosurg Psychiatry. 1984;47 (10): 1087-1090.
16. Grossman SA,Sheidler VR,Gilbert MR.Decreased phenytoin levels in patients receiving chemotherapy.Am J Med. 1989;87 (5): 505-510.